Piper methysticum (kava kava)

Alternative Medicine Review

Volumn 3, Issue 6, 1998, Pages 458-460

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; KAVA; PLANT EXTRACT;

ARTICLE; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; HUMAN; MEDICINAL PLANT;

ANTI-ANXIETY AGENTS; CENTRAL NERVOUS SYSTEM; HUMANS; KAVA; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 0032238295     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shulgin AT. The narcotic pepper - The chemistry and pharmacology of Piper methysticum and related species. Bull Narc 1973;25:59-74.
2. Wren RC. Potter's New Cyclopaedia Of Botanical Drugs and Preparations. Saffron Waiden: C.W. Daniel Company Limited; 1988:201.
3. Davies LP, Drew CA, Duffield P, et al. Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol 1992;71:120-126.
4. Keledjian J, Duffield PH, Jamieson DD, et al. Uptake into mouse brain of four compounds present in the psychoactive beverage kava. J Pharm Sci 1988;77:1003-1006.
5. Seitz U, Schule A, Gleitz J. [3H]-monoamine uptake inhibition properties of kava pyrones. Planta Med 1997;63:548-549.
6. Klohs MW, Keller F, Willimas RE, et al. A chemical and pharmacological investigation of Piper methysticum Forst J Medication Pharm Chem 1959;1:95-103.
7. Kretzschmar R, Meyer HJ. Comparative studies on the anticonvulsant activity of the pyrone compounds of Piper methysticum Forst. Arch Int Pharmacodyn 1969;177:261-267.[Article in German]
8. Meyer HJ. Pharmacology of kava. In: Efron DH, Holmsted B, Kline NS, eds. Ethnopharmacologic Search for Psychoactive Drugs. New York: Raven Press; 1979:133.
9. + channel receptor sites. Eur J Pharmacol 1996;315:89-97.
10. Gleitz J, Beile A, Peters T. (+/-)-Kavain inhibits veratridine-activated voltage-dependent Na(+)-channels in synaptosomes prepared from rat cerebral cortex. Neuropharmacology 1995;34:1133-1138.
11. 2+ and glutamate-release of rat cerebrocortical synaptosomes. Neuropharmacology 1996;35:179-186.
12. Jamieson DD, Duffield PH. The antinocioceptive actions of kava components in mice. Clin Exp Pharmacol Physiol 1990;17:495-507.
13. Bruggemann F, Meyer HJ. [Die analgetische Wirkung der kawa-inhaltsstoffe dihydrokawain und dihydromethistizin.] Arzneimittelforschung 1963;13:407-409.[Article in German]
14. Lebot V, Merlin M, Linstrom L. Kava the Pacific Drug. New Haven, CT: Yale University Press; 1992:10.
15. Baldi D. [Sulle proprieta farmacologische del Piper methysticum.] Terapia moderna 1980:359-364.
16. Kinzler E, Kromer J, Lehmann. Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks. Arzneimittelforschung 1991;41:584-588.
17. Warnecke G. Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490. Fortschr Med 1991;109:119-122.
18. Woelk H, Kapoula S, Lehrl S, et al. Treatment of patients suffering from anxiety - double-blind study: Kava special extract versus benzodiazepines. Ztschr Allegemeinmed 1993;69:271-277.
19. Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders - a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 1997;30:1-5.
20. Heinze HJ, Munthe TF, Steitz J, Matzke M. Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials. Pharmacopsychiatry 1994;27:224-230.
21. Munte TF, Heinze HJ, Matzke M, Steitz J. Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task. Neuropsychobiology 1993;27:46-53.
22. Gleitz J, Beile A, Wilkens P, et al. Antithrombotic action of the kava pyrone (+)-kavain prepared from Piper methysticum on human platelets. Planta Med 1997;63:27-30.
23. Backhauss C, Krieglstein J. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol 1992;215:265-269.
24. Locher CP, Burch MT, Mower HF. Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol 1995;49:23-32.
25. Keller F, Klohs MW. A review of the chemistry and pharmacology of the constituents of Piper methysticum. Lloydia 1963;26:1-15.
26. Almeida JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam. Ann Intern Med 1996;125:940-941.
27. Schelosky L, Raffauf C, Jendroska K, Poewe W. Kava and dopamine antagonism. J Neurol Neurosurg Psychiatry 1995;58:639-640.